LYEL

Lyell Immunopharma Inc

Jun 15 • 11:01AM ET

13.54

+0.04 0.30 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: EDIT BEAM NTLA BMRN CRSP INCY KRYS AXSM NBIX VSTM

| Held by: VTI VXF SCHA IBB VHT AVSC DFAS DFMC SCHB PRFZ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-12.74	Insider Own	66.69%	Shs Outstand	23.33M	Perf Week	9.99%
Market Cap	315.94M	Forward P/E	-	EPS next Y	-7.99	Insider Trans	6.58%	Shs Float	7.77M	Perf Month	-28.81%
Enterprise Value	110.77M	PEG	-	EPS next Q	-2.03	Inst Own	18.91%	Short Float	17.42%	Perf Quarter	-35.92%
Income	-246.41M	P/S	10531.45	EPS this Y	52.16%	Inst Trans	0.56%	Short Ratio	14.65	Perf Half Y	-59.47%
Sales	0.03M	P/B	1.15	EPS next Y	-4.00%	ROA	-63.15%	Short Interest	1.35M	Perf YTD	-56.01%
Book/sh	11.73	P/C	1.24	EPS next 5Y	23.93%	ROE	-80.76%	52W High	45.00 -69.91%	Perf Year	39.01%
Cash/sh	10.89	P/FCF	-	EPS past 3/5Y	-2.70% 0.99%	ROIC	-78.69%	52W Low	8.46 60.05%	Perf 3Y	-82.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-92.48% -65.85%	Gross Margin	-33545.16%	Volatility	6.77% 8.65%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3692.45	EPS Y/Y TTM	49.06%	Oper. Margin	-620790.32%	ATR (14)	1.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.23	Sales Y/Y TTM	-52.31%	Profit Margin	-794858.06%	RSI (14)	35.70	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	7.23	EPS Q/Q	68.79%	SMA20	-9.88%	Beta	-0.04	Target Price	37.17
Payout	-	Debt/Eq	0.18	Sales Q/Q	-71.43%	SMA50	-29.03%	Rel Volume	0.62	Prev Close	13.50
Employees	161	LT Debt/Eq	0.14	Earnings	May 06 AMC	SMA200	-34.74%	Avg Volume	92.39K	Price	13.54
IPO	Jun 17, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.14% -33.33%	Trades		Volume	15,681	Change	0.30%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)